1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Exploring the Impact of Nanoparticle Stealth Coatings in Cancer Models: From PEGylation to Cell Membrane-Coating Nanotechnology

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Nanotechnological platforms offer advantages over conventional therapeutic and diagnostic modalities. However, the efficient biointerfacing of nanomaterials for biomedical applications remains challenging. In recent years, nanoparticles (NPs) with different coatings have been developed to reduce nonspecific interactions, prolong circulation time, and improve therapeutic outcomes. This study aims to compare various NP coatings to enhance surface engineering for more effective nanomedicines. We prepared and characterized polystyrene NPs with different coatings of poly(ethylene glycol), bovine serum albumin, chitosan, and cell membranes from a human breast cancer cell line. The coating was found to affect the colloidal stability, adhesion, and elastic modulus of NPs. Protein corona formation and cellular uptake of NPs were also investigated, and a 3D tumor model was employed to provide a more realistic representation of the tumor microenvironment. The prepared NPs were found to reduce protein adsorption, and cell-membrane-coated NPs showed significantly higher cellular uptake. The secretion of proinflammatory cytokines in human monocytes after incubation with the prepared NPs was evaluated. Overall, the study demonstrates the importance of coatings in affecting the behavior and interaction of nanosystems with biological entities. The findings provide insight into bionano interactions and are important for the effective implementation of stealth surface engineering designs.

          Related collections

          Most cited references66

          • Record: found
          • Abstract: not found
          • Article: not found

          Analysis of nanoparticle delivery to tumours

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Engineering precision nanoparticles for drug delivery

            In recent years, the development of nanoparticles has expanded into a broad range of clinical applications. Nanoparticles have been developed to overcome the limitations of free therapeutics and navigate biological barriers — systemic, microenvironmental and cellular — that are heterogeneous across patient populations and diseases. Overcoming this patient heterogeneity has also been accomplished through precision therapeutics, in which personalized interventions have enhanced therapeutic efficacy. However, nanoparticle development continues to focus on optimizing delivery platforms with a one-size-fits-all solution. As lipid-based, polymeric and inorganic nanoparticles are engineered in increasingly specified ways, they can begin to be optimized for drug delivery in a more personalized manner, entering the era of precision medicine. In this Review, we discuss advanced nanoparticle designs utilized in both non-personalized and precision applications that could be applied to improve precision therapies. We focus on advances in nanoparticle design that overcome heterogeneous barriers to delivery, arguing that intelligent nanoparticle design can improve efficacy in general delivery applications while enabling tailored designs for precision applications, thereby ultimately improving patient outcome overall.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Principles of nanoparticle design for overcoming biological barriers to drug delivery.

              Biological barriers to drug transport prevent successful accumulation of nanotherapeutics specifically at diseased sites, limiting efficacious responses in disease processes ranging from cancer to inflammation. Although substantial research efforts have aimed to incorporate multiple functionalities and moieties within the overall nanoparticle design, many of these strategies fail to adequately address these barriers. Obstacles, such as nonspecific distribution and inadequate accumulation of therapeutics, remain formidable challenges to drug developers. A reimagining of conventional nanoparticles is needed to successfully negotiate these impediments to drug delivery. Site-specific delivery of therapeutics will remain a distant reality unless nanocarrier design takes into account the majority, if not all, of the biological barriers that a particle encounters upon intravenous administration. By successively addressing each of these barriers, innovative design features can be rationally incorporated that will create a new generation of nanotherapeutics, realizing a paradigmatic shift in nanoparticle-based drug delivery.
                Bookmark

                Author and article information

                Journal
                ACS Appl Mater Interfaces
                ACS Appl Mater Interfaces
                am
                aamick
                ACS Applied Materials & Interfaces
                American Chemical Society
                1944-8244
                1944-8252
                30 December 2023
                17 January 2024
                : 16
                : 2
                : 2058-2074
                Affiliations
                []Department of Applied Physics, Faculty of Science, University of Granada , 18071 Granada, Spain
                []Department of Human Anatomy and Embryology, Faculty of Medicine, University of Granada , 18016 Granada, Spain
                [§ ]Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA) , 18012 Granada, Spain
                []Biopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research (CIBM), University of Granada , 18016 Granada, Spain
                []Excellence Research Unit Modelling Nature (MNat), University of Granada , 18016 Granada, Spain
                [# ]BioFab i3D—Biofabrication and 3D (bio)printing laboratory, University of Granada , 18100 Granada, Spain
                []Faculty of Biology, Calzada de las Américas and University, Ciudad Universitaria , 80040 Culiacán, Sinaloa, Mexico
                Author notes
                Author information
                https://orcid.org/0000-0002-5525-2657
                https://orcid.org/0000-0001-8941-5752
                https://orcid.org/0000-0002-4996-8261
                https://orcid.org/0000-0002-9560-4629
                Article
                10.1021/acsami.3c13948
                10797597
                38159050
                7706d1f0-4894-4d49-8a6d-e66560351e28
                © 2023 The Authors. Published by American Chemical Society

                Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained ( https://creativecommons.org/licenses/by/4.0/).

                History
                : 18 September 2023
                : 19 December 2023
                : 19 December 2023
                Funding
                Funded by: Ministerio de Ciencia e Innovación, doi 10.13039/501100004837;
                Award ID: FPU18/05336
                Funded by: Universidad de Granada, doi 10.13039/501100006393;
                Award ID: PPJIA2021.21
                Funded by: Ministerio de Ciencia e Innovación, doi 10.13039/501100004837;
                Award ID: RTI2018.101309B-C22
                Funded by: Ministerio de Ciencia e Innovación, doi 10.13039/501100004837;
                Award ID: RTI2018.101309B-C21
                Funded by: Ministerio de Ciencia e Innovación, doi 10.13039/501100004837;
                Award ID: PRE2019-088029
                Funded by: Ministerio de Ciencia e Innovación, doi 10.13039/501100004837;
                Award ID: PID2022-140151OB-C22
                Funded by: Ministerio de Ciencia e Innovación, doi 10.13039/501100004837;
                Award ID: PID2022-140151OB-C21
                Funded by: Ministerio de Ciencia e Innovación, doi 10.13039/501100004837;
                Award ID: PID2021-124363OA-I00
                Funded by: Ministerio de Ciencia e Innovación, doi 10.13039/501100004837;
                Award ID: FPU19/02045
                Categories
                Research Article
                Custom metadata
                am3c13948
                am3c13948

                Materials technology
                nanoparticles,coatings,cell membranes,biointerfacing,protein corona,3d cell culture

                Comments

                Comment on this article